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Considering the high prevalence of metabolic syndrome and
its association with cardiovascular mortality, we prospectively
evaluated the role of diet in the incidence of metabolic
syndrome in renal transplant recipients. Our prospective
cohort of 160 adult renal allograft recipients was followed
for 1 year and had no existing metabolic syndrome or
diabetes mellitus. Routine dietary intakes were assessed with
food-frequency questionnaires, and metabolic syndrome was
defined according to the Adult Treatment Panel III guidelines.
We identified 3 major patterns by factor analysis, consisting
of those recipients predominantly consuming fats and
sugars, those predominantly consuming whole grain, and the
Mediterranean diet. When analyzed by multivariable logistic
regression and after controlling for potential confounders,
subjects in the highest tertile of scores for the Mediterranean
diet had a significantly lower odds of metabolic syndrome
than those in the lowest tertile. Subjects in the highest tertile
of scores for consuming fats and sugars had significantly
greater odds of metabolic syndrome compared with those in
the lowest tertile. Our study shows that the Mediterranean
dietary pattern is associated with a reduced risk of metabolic
syndrome in renal transplant recipients.
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Cardiovascular diseases (CVD) contribute to 47% of all deaths in
renal transplant recipients.1 Compared with the general popula-
tion, renal transplant recipients aged 25–34 years have a 10-fold
higher risk of death from CVD.2,3 This may be due in part to
the increased cardiovascular (CV) risk associated with immuno-
suppressive medications.4 Central to the development of CVD
in renal transplantation are weight gain, hyperlipidemia, hyper-
tension (HTN), and glucose intolerance, which characterize
the metabolic syndrome (MS).5 Apart from contributing to post-
transplantation cardiovascular mortality, and morbidity, detecting
the MS has also been proposed as an underlying transplantation-
related risk factor for chronic renal allograft dysfunction.6
Although several studies have evaluated the adverse effect of
immunosuppressive agents in transplant recipients,7 few have
assessed the effects of diet. For instance calcineurin inhibitors
cause post-transplant diabetes mellitus (DM), hypercholesterole-
mia, and HTN.8 Sirolimus has hyperlipidemic effects, accelerating
both hypercholesterolemia, and hypertriglyceridemia and corti-
costeroids can cause the worst CV risk profile, as they induce
many metabolic effects including HTN, new onset DM after
transplantation, hypercholesterolemia, and weight gain.4 Corti-
costeroids may also have an important role in the incidence of
post-transplant MS. The incidence of MS in renal transplant
recipients has been reported to be 57% 1-year post-transplant.9
The MS is a multi-factorial disorder, and diet has an important
role in its development.10 Diet can be considered in terms of
dietary patterns, an approach that has been used to investigate
diet–disease relations.11–13 Dietary patterns address the effect of
the diet as a whole and thus may provide insight beyond the
effects described for single nutrients or foods.11
As no study has evaluated the impact of food pattern on
MS incidence in renal transplant recipients, considering high
prevalence potential and the CVD mortality associated with
MS, we prospectively evaluated the potential role of food
pattern on the incidence of MS at 1 year after transplant.
RESULTS
A total of 160 renal transplant recipients (100 male and 60
female recipients) who completed the FFQ in 2004–2007,
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participated in the final analysis. Mean age and body mass
index (BMI) of our participants at baseline were 40±13 years
and 22±4 kg/m2, respectively. The coefficient tau-b between
waist circumference (WC) and BMI was also high (0.72) and
statistically significant (Po0.001). During the 1-year follow-
up period, we had 56 (35%) and 58 (36%) incident MS based
on high BMI and high WC (including imputed WCs),
respectively. With regard to factors associated with the MS,
101 patients (63%) presented with hypertriglyceridemia or
required specific treatment for this lipid abnormality, 92
(58%) had low high-density lipoprotein (HDL) levels or
required specific treatment for this lipid abnormality, 83
(52%) had HTN or required the use of antihypertensive
medication, 29 (18%) had high BMI and 27 patients (17%)
had high fasting glucose levels or required the use of anti-
diabetic medication during the 1-year follow-up period. So a
high triglyceride level was the most prevalent component.
As people do not eat isolated nutrients but foods with
combinations of nutrients and because of the high level of
intercorrelation among some nutrients makes it difficult to
examine their separate effects and ‘single nutrient’ analysis
may potentially be confounded by the effect of dietary
patterns, it has recently been proposed to study overall
dietary patterns by factor analysis which would parallel more
closely the real world.14 Factor analysis is a multivariate
statistical technique, which uses information reported on
food-frequency questionnaires14 to identify patterns of food
consumption. It aggregates specific food items on the basis of
the degree to which food items in the dataset are correlated
with one another (Table 1) to characterize the eating
behavior. Three major dietary patterns were identified and
labeled; the fats and sugars, the whole grain, and the
Mediterranean dietary patterns on the basis of food groups
with high factor loadings. The factor-loading matrixes for
these dietary patterns are shown in Table 2. Other minor
Table 1 | Food grouping used in the dietary pattern analyses
Food group Food items and food preparations
High-fat dairy High-fat milk, whole milk, chocolate milk, cream, high-fat yogurt, cream yogurt, cream cheese, other cheeses, ice cream, doogh
(an Iranian yogurt drink with a composition similar to that of whole milk)
Low-fat dairy Skim or low-fat milk, low-fat yogurt
Saturated fats Butter, margarine, mayonnaise, animal oil
Polyunsaturated
fats
Vegetable oils (except for olive oil)
Red meat Beef, lamb, beef liver
Processed meat Sausages, hamburgers
Poultry Chicken with or without skin
Fish Canned tunafish, other fish
Fruits All types
Vegetables All types (except for potato)
Potatoes Boiled potato
Whole grain Dark Iranian breads (barbari, taftoon, sangak), barley bread, popcorn, cornflakes, wheat germ, bulgur
Refined grain White breads (lavash, baguettes), noodles, pasta, toasted bread, milled barley, sweet bread, white flour, starch, biscuits, cake
Rice White rice
Olives Olives, olive oils
Legumes Beans, peas, lima beans, broad beans, lentils, soy
Nuts All types
Soft drinks Coke, Pepsi, other soft drinks, cordial, low-calorie colas, other low-calorie soft drinks
Confectionary Chocolates, hard candy, jam, jelly, sugar, honey, gaz (an Iranian confectionery made of sugar, nuts, and tamarisk), confections
Salty snacks Fried potatoes, chips
Pizza Pizza
Eggs Eggs
Salt Salt
Tea and coffee Tea and coffee
Table 2 | Factor-loading matrix for major dietary patternsa
Dietary pattern
Food group Fats and sugars Whole grain Mediterranean
High-fat dairy 0.57 — —
Rice 0.56 — —
Soft drinks 0.55 — —
Confectionary 0.53 — —
Salty snacks 0.50 0.41 —
Saturated fats 0.47 — —
Pizza 0.42 — —
Poultry 0.39 0.30 0.22
Refined grain 0.38 0.27 —
Tea and coffee 0.32 — —
Processed meat 0.31 — —
Potatoes 0.31 — —
Eggs — 0.67 —
Salt — 0.60 —
Polyunsaturated fats — 0.48 —
Whole grain — 0.48 0.24
Red meat — 0.43 —
Legumes 0.27 0.39 0.29
Nuts — 0.30 0.27
Vegetables — — 0.80
Fruits 0.26 — 0.60
Olives 0.32 — 0.48
Fish — — 0.34
Low-fat dairy — — 0.25
aValues o0.20 were excluded for simplicity.
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dietary patterns were identified by factor analysis, but
because of the small variances they explained, we did not
consider them in subsequent analyses. The fats and sugars
dietary pattern featured high consumption of high-fat dairy,
rice, soft drinks, confectionary, salty snacks, saturated fats,
pizza, poultry, refined grain, tea and coffee, processed meat,
and potatoes. The whole grain dietary pattern was character-
ized by high consumption of whole grain products and
Mediterranean dietary patterns by the higher consumption of
legumes, nuts, vegetables, fruits, olives, fish, and low-fat
dairy. On average, participants who more often followed the
fats and sugars dietary pattern (highest tertile) compared
with less often (lowest tertile) were more likely to report high
intakes of total energy, percentage of fat, total cholesterol,
and less fiber (Table 3). Conversely, participants who more
often followed the whole grain diet (highest tertile) compared
with less often (lowest tertile) were more likely to report
lower dietary intake of total calories, percentage of fat, total
cholesterol and a higher intake of protein and fiber (Table 3).
Compared with participants in the lowest tertile, those in
the highest tertile of the Mediterranean dietary pattern had
significantly higher intakes of energy (ET) and fiber and
lower intake of cholesterol. No significant differences were
found in age, cumulative dose of steroid, and the distribution
of menopause, current smoking, and heavy physical activity
across tertile categories of dietary patterns. Blood pressure,
BMI, and biochemical characteristics of study participants
by tertiles of food patterns at baseline are shown in Table 4.
In comparison with participants in the lowest tertile, those
in the highest tertile of the fats and sugars and whole grain
Table 3 | Descriptive characteristics and dietary intake of participants at baseline: ANOVA for quantitative variables and v2 test
for qualitative variables
Fats and sugars dietary pattern Whole grain dietary pattern Mediterranean dietary pattern
T1 (n=53) T2 (n=53) T3 (n=54) P-value T1 (n=54) T2 (n=53) T3 (n=53) P-value T1 (n=53) T2 (n=53) T3 (n=54) P-value
Age (years) 42±14a 41±12 36±12 NS 41±12 38±12 40±15 NS 37±13 42±12 41±14 NS
Men (%) 63 63 63 NS 63 63 63 NS 63 63 63 NS
Menopause (%) 38 33 16 NS 33 27 27 NS 33 33 22 NS
Current
smoking (%)
2 0 8 NS 4 4 2 NS 2 6 2 NS
Heavy PA (%) 2 0 0 NS 0 2 0 NS 0 2 0 NS
Duration on
dialysis (months)
12±4 8±2 10±3 NS 10±2 11±3 11±3 NS 13±4 12±2 7±1 o0.05
Prednisolone dose
(mg per year)
4089±1736 3717±1910 3536±1957 NS 3394±2125 3804±1755 4129±1677 NS 3681±1952 3592±1994 4061±1660 NS
Family history
of DM (%)
6 2 6 NS 0 6 8 o0.05 4 4 6 NS
TE (kcal/d) 2359±668b 3136±774c 4460±1040 o0.01 3780±1129b 3131±1103 3072±1275 o0.01 2588±910b 3459±1165 3912±1149 o0.01
CHO (% of TE) 57±7 58±7 56±8 NS 56±6 57±8 58±7 NS 56±7 58±7 57±7 NS
Pr (% of TE) 16±2 16±3 16±3 NS 15±2b 17±3 17±3 o0.01 17±3 16±3 17±3 NS
Fat (% of TE) 26±7 24±6d 28±8 o0.05 28±8d 26±6 24±7 o0.05 26±7 26±8 26±7 NS
Fiber (g/d)e 34±13b 23±9 20±10 o0.01 23±13 23±12 29±11f o0.05 15±5b 24±8c 36±12 o0.01
Cholesterol (mg/d)e 182±83 201±83 302±119b o0.01 279±121b 216±101 193±88 o0.01 280±122c 227±106g 179±73 o0.01
ANOVA, analysis of variance; CHO, carbohydrate intake; DM, diabetes mellitus; PA, physical activity; Pr, protein intake; T, tertile; TE, total energy intake.
aX±s.d. (all such values).
bSignificantly different from the other tertiles, Po0.01.
cSignificantly different from the third tertile, Po0.01.
dSignificantly different from the third tertile, Po0.05.
eAdjusted for age and energy intake.
fSignificantly different from the other tertiles, Po0.05.
gSignificantly different from the first tertile, Po0.05.
Table 4 | BMI, blood pressure, and biochemical characteristics of participants at baseline
Fats and sugars dietary pattern Whole grain dietary pattern Mediterranean dietary pattern
T1
(n=53)
T2
(n=53)
T3
(n=54) P-valuea
T1
(n=54)
T2
(n=53)
T3
(n=53) P-value
T1
(n=53)
T2
(n=53)
T3
(n=54) P-value
BMI (Kg/m2) 23.4±3.4 22.4±6.1 21.1±3.6 NS 22.0±2.1 23.5±5.5 21.4±3.3 NS 22.2±2.4 21.2±3.7 22.4±4.2 NS
SBP (mmHg) 117±22 123±26 115±19 NS 116±18 120±25 116±20 NS 109±15 114±15 129±28 NS
DBP (mmHg) 70±12 70±14 69±11 NS 68±13 73±10 67±13 NS 66±13 68±9 74±12 NS
Cholesterol (mg/dl) 213±50 258±62 240±86 NS 227±28 240±74 230±74 NS 269±84 208±35 225±63 NS
LDL.c (mg/dl) 110±27 137±29 123±38 NS 141±32 126±27 109±34 NS 112±36 122±27 129±33 NS
HDL.c (mg/dl) 60±24 59±24 55±16 NS 60±16 58±23 57±20 NS 58±23 53±21 63±19 NS
TG (mg/dl) 217±102 173±62 350±311b o0.01 220±72 193±101 315±280 NS 323±320 232±102 196±90 NS
FBS (mg/dl) 106±46 86±10 81±6 NS 78±6 85±9 106±46b o0.01 88±8 91±25 100±49 NS
Creatinine (mg/dl) 1.4±0.4 1.2±0.1 1.4±0.3 NS 1.3±0.2 1.3±0.3 1.3±0.3 NS 1.4±0.3 1.4±0.5 1.2±0.1 NS
BMI, body mass index; DBP, diastolic blood pressure; HDL.c, high-density lipoprotein cholesterol; LDL.c, low-density lipoprotein cholesterol; SBP, systolic blood pressure.
aAnalysis of covariance with Bonferroni correction. All values adjusted for age, sex, physical activity, smoking, menopausal status, total energy intake.
bSignificantly different from the other tertiles, Po0.01.
Kidney International (2009) 76, 1199–1206 1201
M Nafar et al.: Mediterranean diets one year following renal transplantation o r ig ina l a r t i c l e
dietary patterns had significantly higher TG and FBS,
respectively at baseline.
Odds Ratio (OR)s for the MS across tertile categories of
dietary pattern scores are presented in Table 5. After control
for age and sex participants in the highest tertile of the
Mediterranean dietary pattern score had lower odds of the
MS (OR: 0.52; 95% CI: 0.21, 1.24) than those in the lowest
tertile, whereas those in the highest tertile of the fats and
sugars dietary pattern score had greater odds of the MS (OR:
1.29; 0.54, 3.06) than did those in the lowest tertile. Further
adjustment for other potentially confounding variables even
enhanced these associations. After additional control for total
energy intake and baseline BMI, the inverse association of the
Mediterranean dietary pattern score and the positive
association of fats and sugars dietary pattern score with the
MS based on either high BMI or high WC became stronger.
However, either before or after adjustment for confounders,
there was no significant overall association between the whole
grain dietary pattern and MS. In the multivariate models,
participants in the highest tertile of the Mediterranean
dietary pattern score had lower odds for two of five compo-
nents of the MS (0.36 (0.10–1.08) and 0.48 (0.17–1.05) for
abnormal glucose homeostasis and high BP, respectively)
(Table 6). In contrast, those in the highest tertile of the fats
and sugars dietary pattern score had significantly higher
odds for high TG, blood pressure and low HDL. However,
the association was not significant for other components
of MS. When we considered BMI changes during follow up
according to tertiles of dietary patterns (Figure 1), we found
that in comparison with those in the lowest tertile of fats
and sugars dietary pattern, subjects in the highest tertile had
significantly higher increase in BMI than other categories.
Higher adherence to whole grain or Mediterranean dietary
patterns was not associated with BMI change.
DISCUSSION
The major novel findings of our analysis are as follows: (1)
regarding MS definition of the National Cholesterol Educa-
tional Expert Panel in our patients, we observed a 35%
incidence of the MS at 12 months after renal transplantation.
Table 5 |Multivariate adjusted odds ratios (95% CIs) for metabolic syndrome (MS) across tertile (T) categories of dietary
pattern scores
Fats and sugars dietary pattern Whole grain dietary pattern Mediterranean dietary pattern
T1
(n=53)
T2
(n=53)
T3
(n=54)
P for
trend
T1
(n=54)
T2
(n=53)
T3
(n=53)
P for
trend
T1
(n=53)
T2
(n=53)
T3
(n=54)
P for
trend
Odds ratiosa
Model 1 1.00 0.99 (0.42–2.32) 1.29 (0.54–3.06) 0.57 1.00 0.95 (0.40–2.20) 0.88 (0.38–2.04) 0.93 1.00 0.63 (0.27–1.48) 0.52 (0.21–1.24) 0.14
Model 2 1.00 1.00 (0.42–2.42) 1.21 (0.89–2.97) 0.18 1.00 0.85 (0.35–2.06) 0.80 (0.33–1.95) 0.63 1.00 0.58 (0.24–1.41) 0.45 (0.17–1.14) 0.09
Model 3 1.00 1.39 (0.53–3.62) 2.96 (1.10–7.85) o0.05 1.00 0.76 (0.30–1.89) 0.70 (0.27–1.79) 0.46 1.00 0.57 (0.22–1.26) 0.44 (0.15–0.98) o0.05
Model 4 1.00 2.66 (0.90–7.86) 6.38 (1.38–8.87) o0.01 1.00 0.95 (0.35–2.54) 0.94 (0.35–2.52) 0.91 1.00 0.48 (0.17–1.31) 0.29 (0.11–0.90) o0.05
Odds ratiosb
Model 1 1.00 0.82 (0.35–1.95) 1.35 (0.56–3.21) 0.50 1.00 0.88 (0.38–2.05) 0.79 (0.34–1.87) 0.60 1.00 0.61 (0.26–1.44) 0.55 (0.23–1.32) 0.18
Model 2 1.00 0.82 (0.34–1.99) 1.26 (0.51–3.09) 0.63 1.00 0.79 (0.33–1.91) 0.75 (0.31–1.82) 0.53 1.00 0.57 (0.23–1.38) 0.52 (0.21–1.10) 0.10
Model 3 1.00 1.11 (0.59–2.62) 2.26 (1.03–6.92) o0.05 1.00 0.74 (0.30–1.86) 0.70 (0.28–1.78) 0.47 1.00 0.52 (0.21–1.24) 0.45 (0.16–0.97) o0.05
Model 4 1.00 1.70 (0.60–4.78) 5.27 (2.11–9.75) o0.01 1.00 0.91 (0.34–2.41) 0.90 (0.34–2.36) 0.84 1.00 0.44 (0.16–1.18) 0.30 (0.10–0.89) o0.01
aOdds ratio of MS, defined as the presence of X3 of the following components: Obesity (BMIX30 kg/m2); low serum HDL cholesterol (o40 for men and o50mg/dl for
women) or specific treatment for this lipid abnormality; high serum triacylglycerol concentrations (X150mg/dl) or specific treatment for this lipid abnormality; elevated
blood pressure (X130/85mmHg) or use of antihypertensive medication; and abnormal glucose homeostasis (fasting plasma glucose X110mg/dl) or use of antidiabetic
medication.
bOdds ratio of MS based on waist or imputed waist 4102 cm for men and 488 cm for women.
Model 1, age and sex adjusted. Model 2, further adjusted for cigarette smoking (yes or no), physical activity, dialysis mode and its duration before transplantation, the
cumulative dose of steroids at 1 year after transplant, menopausal status, and family history of diabetes and stroke. Model 3, additionally adjusted for energy intake. Model 4,
additionally adjusted for baseline BMI.
Table 6 |Multivariate-adjusted odds ratios (95% CIs) for components of metabolic syndrome across tertile (T) categories of
dietary pattern scores
Fats and sugars dietary pattern Whole grain dietary pattern Mediterranean dietary pattern
T1
(n=53)
T2
(n=53)
T3
(n=54)
P for
trend
T1
(n=54)
T2
(n=53)
T3
(n=53)
P for
trend
T1
(n=53)
T2
(n=53)
T3
(n=54)
P for
trend
High BMI 1.00 1.34 (0.19–6.47) 3.28 (0.83–9.79) 0.40 1.00 0.19 (0.02–1.47) 1.34 (0.25–7.66) 0.61 1.00 1.27 (0.20–8.07) 0.98 (0.12–7.53) 0.95
High TG 1.00 1.28 (0.50–3.29) 4.52 (1.90–8.46) o0.01 1.00 1.05 (0.42–2.01) 1.11 (0.45–2.72) 0.81 1.00 0.78 (0.31–1.99) 0.69 (0.25–1.93) 0.49
High BP 1.00 2.87 (1.06–6.75) 7.23 (1.64–8.87) o0.01 1.00 1.04 (0.41–2.45) 0.72 (0.29–1.76) 0.46 1.00 0.68 (0.27–1.51) 0.48 (0.17–1.05) o0.05
High FBS 1.00 2.65 (0.49–6.60) 1.67 (0.20–8.90) 0.54 1.00 1.05 (0.22–5.11) 3.13 (0.73–7.38) 0.09 1.00 0.63 (0.16–1.44) 0.36 (0.10–1.08) o0.05
Low HDL 1.00 1.82 (0.69–3.79) 3.79 (1.08–7.43) o0.05 1.00 1.90 (0.35–2.30) 0.51 (0.20–1.29) 0.14 1.00 0.57 (0.22–1.46) 0.63 (0.23–1.80) 0.81
High BMI defined as BMIX30 kg/m2; low HDL cholesterol defined as serum HDLo40 for men ando50mg/dl for women or specific treatment for this lipid abnormality; high-
serum triacylglycerol concentrations defined as X150mg/dl or specific treatment for this lipid abnormality; high blood pressure defined as X130/85mmHg or use of
antihypertensive medication; and high FBS defined as fasting plasma glucose X110mg/dl or use of antidiabetic medication. All values adjusted for age, sex, cigarette
smoking, physical activity, dialysis mode and its duration before transplantation, the cumulative dose of steroids at 1 year after transplant, menopausal status, family history
of diabetes and stroke, energy intake, and baseline BMI.
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(2) The Mediterranean dietary pattern was associated with
lower risks of MS, whereas the fats and sugars dietary pattern
was associated with higher risks of MS in renal transplant
recipients.
Metabolic syndrome represents one of the major risks for
the graft.15 Moller and Kaufman16 report an incidence of the
metabolic syndrome in 20–30%, with the incidence in people
460 years of age rising to 40%. The MS therefore affects
almost half of all transplant donors and recipients16 and as
the cluster of modifiable factors that early intervention can
probably prevent more deleterious consequences cannot be
ignored.17 The increase in MS risk in renal transplant
recipients compared with the normal population may be
attributed to immunosuppressive medications that increase
weight and body fat, reduced level of physical activity in these
patients, appetite improvement, and some wasting metabolic
processes associated with previous renal failure.18 In
particular, corticosteroids have long been implicated in
increasing CV risk by causing multiple metabolic effects,
including HTN, DM, dyslipidemia, and weight gain.19 Teplan
et al.20 suggested that the metabolic syndrome can be
effectively treated by the use of corticosteroid withdrawal
and statins, but there is a high risk of acute rejection and
adverse reactions to pharmacotherapy. Although lifestyle
modification can be difficult to implement, it is a safer
alternative. The incidence of the MS (35%) in our sample of
the Iranian renal transplant population was higher than the
incidence of the syndrome in many studies.20–24 These
differences underscore the importance of dietary modifica-
tion in preventing the metabolic syndrome and can be
attributed, partially, to the high frequency of the adoption of
fats and sugars diet by our people, which showed significant
increase on the odds of having the MS.
Data on the association of dietary patterns with MS are
limited to healthy people. In the Malmo Diet and Cancer
Cohort,25 features of the MS were more prevalent in women
with the ‘white-bread’ dietary pattern and less prevalent in
women with the ‘milk-fat’ pattern. In a cross-sectional study
in a British population,26 a dietary pattern characterized by
high consumption of fruit and vegetables and low consump-
tion of processed meat and fried foods was inversely
associated with features of the MS. However, that study
was limited by the lack of control for physical activity, which
tends to be associated with dietary patterns.27
To our knowledge, this is the first investigation in which
major dietary patterns identified by factor analysis have been
associated directly with the MS in a group of renal transplant
recipients. We found in this study that the Mediterranean
dietary pattern is associated with lower risk of metabolic
abnormalities, whereas the fats and sugars dietary pattern is
related to higher risk of adverse metabolic risk factors in renal
transplant recipients. The main characteristics of this style
diet include an abundance of plant food, olive oil as the
principal source of fat, fish and poultry consumed in low-to-
moderate amounts, relatively low consumption of red meat.
It seems to be no individual component in this diet that is
wholly responsible for the lower risk of MS and its
components. Rather it is likely the interaction between many
components of the diet or the overall diet quality offers
protection against the MS.28 Several mechanistic links offer
potential explanations of the Mediterranean diet’s protective
effect on the MS. One of the most desirable features of the
Mediterranean diet is its ability to improve CVD risk
factors,29–31 which account for the greater CV risk associated
with metabolic diseases. Beyond this, epidemiological and
interventional studies have revealed a protective effect of the
Mediterranean diet against mild chronic inflammation and
its metabolic complications.29,30,32,33 More recent studies
emphasize that inflammation and oxidative stress have a
central role in atherosclerosis, and it is well-established that
CRP is a cardiovascular risk marker in allograft recipients.34
A Mediterranean dietary pattern, which is rich in nutrients
with favorable anti-inflammatory properties and poor in
pro-inflammatory nutrients may protect from autoimmune
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Figure 1 |BMI changes during follow-up across tertiles of dietary pattern scores.
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or other chronic diseases that are related to chronic
inflammation, including visceral obesity, type II DM, or the
MS.29,35 Moreover, people who eat a Mediterranean diet that
includes virgin olive oil reduce their levels of oxidized LDL,
as suggested by the results of a subgroup analysis of the
PREDIMED study.36
Regarding both strengths and limitations of our study, the
main strength of our study is its novelty and prospective
design; in this cohort, we clearly showed an independent
protective role for Mediterranean diet in the development of
MS. The several limitations of our analysis also deserve
comments. Given the study’s observational design we could
not adjust some confounding variables such as socio-
economic status. Limitations of the FFQ also apply to dietary
pattern analyses that are based on dietary information
collected by this method. Another limit is the absence of
clinical outcomes: both the number of patients and the length
of follow-up obviously preclude any possible conclusion on
the future destiny of the graft. Renal function, however,
remained stable in all recipients during the 12-month period
and, although creatinine clearance may overestimate the true
GFR, all recipients showed high values of creatinine
clearance. Last but not the least we used BMI and imputed
WC instead of direct measurement of abdominal obesity to
define MS. Recipients with similar BMIs may have absolutely
different amounts of visceral fat, the adipose tissue known to
be associated with the greatest metabolic risk.37
In conclusion, the current findings indicate that a dietary
pattern characterized by high consumption of fruit, vege-
tables, poultry, olives, fish, low-fat dairy, legumes, and nuts
is associated with a reduced risk of MS in renal transplant
recipients. In contrast, a dietary pattern with high amounts of
refined grains, red meat, butter, processed meat, and high-fat
dairy products and low amounts of vegetables and low-fat
dairy products is associated with a greater risk of the MS.
MATERIALS AND METHODS
Study population
In this prospective cohort study patient and disease characteristic
data were prospectively collected on recipients of a first or second
living-donor kidney transplant recipients aged over 18 years in
Labbafinejad hospital in Tehran, Iran, who underwent renal
transplantation between 2004 and 2007 and were on the standard
triple immunosuppressive regimen (cyclosporine (Sandimmune
or neoral), prednisolone, and my–cophenolate mofetil (Cellcept)
or azathioprine (Imuran)). Out of 382 recipients invited to
participate in the study; 371 agreed to do so. Participants with a
history of pretransplant DM (n¼ 53) or cancer (n¼ 6) (because of
possible disease-related changes in diet), who were on immuno–-
suppressive therapy other than the standard triple regimen (n¼ 4),
who were on sirolimus (Rapamune) therapy (n¼ 31), with missed
variables (n¼ 46), with missed X10% food-consumption frequen-
cies (n¼ 9), with prevalent MS (n¼ 33) and unstable renal function
at 1 year after transplantation (n¼ 12); defined as a serum creatinine
level 41.5 mg/dl, were excluded. We also had 17 lost to follow up.
These exclusions left 160 patients (100 male and 60 female patients)
for this cohort who were followed for 1 year. Written informed
consent was obtained from each participant. The study was
approved by the research council of Urology and Nephrology
Research Center, Shahid beheshti University, MC.
Assessment of dietary intake
Dietary intake was assessed by using a 168-item semi-quantitative
FFQ at 2 months after transplant. All of the questionnaires were
administered by a trained dietitian. The FFQ consisted of a list of
foods with standard serving sizes commonly consumed by Iranians.
Participants were asked to report their frequency of consumption of
a given serving of each food item during the previous year on a daily,
weekly, or monthly basis. The reported frequency for each food item
was then converted to a daily intake. Portion sizes of consumed
foods were converted to grams by using household measures.38
Because of the large number of the food items relative to the number
of participants, we assigned each food item into 1 of 24 defined food
groups (Table 1). The basis for placing a food item in a certain food
group was the similarity of nutrients. A previous validation study of
this FFQ revealed good correlations between dietary intakes assessed
by a similar FFQ and those from multiple days of 24-h dietary recalls
completed during an earlier yearlong study.39
Assessment of anthropometric measures
Weight was measured while the subjects were minimally clothed and
not wearing shoes; weight was measured with analog scales and
recorded to the nearest 100 g. Height was measured by using a tape
measure while the subjects were standing, were not wearing shoes,
and had the shoulders in a normal position. BMI was calculated as
weight (in kg) divided by height2 (in m2). WC was measured at the
narrowest level over light clothing, by using an unstretched tape
measure, without any pressure to the body surface; measurements
were recorded to the nearest 0.1 cm.40 To reduce errors, all
measurements were taken by the same technician.
Assessment of biomarkers
A blood sample was drawn between 0700 and 0900 hours into
evacuated tubes after an overnight (12 h) fast. Blood samples were
taken while the subjects were sitting and according to a standard
protocol; the samples were centrifuged for 10 min at 500 g and
at 41C within 30–45 min of collection. Samples were analyzed
by using an autoanalyzer (Selectra 2; Vital Scientific, Spankeren,
Netherlands). Fasting plasma glucose was measured on the day of
blood collection by the enzymatic colorimetric method and using
glucose oxidase. Serum triacylglycerol concentrations were assayed
with triacylglycerol kits (Pars Azmoon, Tehran, Iran) by using
enzymatic colorimetric tests with glycerol phosphate oxidase. HDL
cholesterol was measured after precipitation of the apolipoprotein
B-containing lipoproteins with phosphotungistic acid. The inter-
assay and intraassay CVs of this method were o10%.
Assessment of blood pressure
For blood pressure measurements, participants were first asked to
rest for 15 min. Then, a trained physician measured blood pressure
of the participants twice, in a sitting position, by using a standard
mercury sphygmomanometer, and thereafter the mean of two
measurements was considered as the participant’s blood pressure.
Systolic blood pressure was defined as the appearance of the first
sound (Korotkoff phase-1), and diastolic blood pressure was defined
as the disappearance of the sound (Korotkoff phase-5) during
deflation of the cuff at a 2–3-mm/s rate of decrement of the mercury
column.
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Assessment of other variables
Physical activity level was determined using the Lipid Research
Clinics41 questionnaire, which is a simple and comprehensible
measure including four questions; no special education is needed to
complete this questionnaire. The individuals are divided into three
groups of light, moderate, and heavy physical activity according to
this questionnaire. Additional covariate information regarding age,
menopausal status, medical history, and current use of medications
was obtained with questionnaires. Smoking statuses were defined
according to WHO guidelines; current smoker was defined as a
person who smokes cigarettes daily or occasionally. Dialysis mode
(none, hemodialysis, or peritoneal dialysis) and its duration before
transplantation also were recorded. The cumulative dose of steroids
at 1 year after transplant was considered as a potential covariate. As
none of our subjects used tacrolimus, it was not considered as a
potential covariate.
Definition of terms
The metabolic syndrome was defined as the presence of X3 of the
following components as recommended by Adult Treatment Panel
III (ATP III):42 Obesity (BMI X30 kg/m2); low serum HDL
cholesterol (o40 for male and o50 mg/dl for female patients) or
specific treatment for this lipid abnormality; high serum triacylgly-
cerol concentrations (X150 mg/dl) or specific treatment for this
lipid abnormality; elevated blood pressure (X130/85 mm Hg) or use
of antihypertensive medication; and abnormal glucose homeostasis
(fasting plasma glucose X110 mg/dl) or use of anti-diabetic
medication. We utilized the BMI to define obesity because waist
circumference was not obtained in all patients as from Meigs et al.43
who showed that this change had little effect on the applicability of
the definition. In addition in the National Health and Nutrition
Examination Survey Study both variables were highly correlated. MS
was also determined according to the NCEP-ATP-III criteria (WC or
imputed WC 4102 cm in men and 488 cm in women). The
presence of the MS was assessed at 1 year after renal transplantation.
Statistical analysis
To identify major dietary patterns based on the 24 food groups, we
used principal component analysis, and the factors were rotated by
orthogonal transformation. The natural interpretation of the factors
in conjunction with eigenvalues41 and the Scree test44 determined
whether a factor should be retained. The Scree plot is a plot of the
eigenvalues of derived factors. The eigenvalues of the factors
dropped substantially after the third factor and remained more
similar to each other after the fourth factor. The derived factors
(dietary patterns) were labeled on the basis of our interpretation of
the data and of a higher score suggests better adherence to a certain
dietary pattern. The factor score for each pattern was calculated by
summing intakes of food groups weighted by their factor loadings,44
and each participant received a factor score for each identified
pattern. We categorized participants by tertiles of dietary pattern
scores. We used gender-specific tertiles as there are substantial
gender differences in dietary consumption. Hence, we had three
groups: first group – lowest tertile of men and lowest tertile
of women, second group – mid tertile of men and mid-tertile
of women, third group – highest tertile of men and highest tertile of
women. One-way analysis of variance with Bonferroni post hoc
comparisons was performed to evaluate significant differences in
general characteristics across tertile categories of dietary pattern
scores; the distribution of qualitative variables across tertiles was
evaluated by using w2 tests. Age- and energy-adjusted means for
dietary variables across tertiles of dietary pattern scores were
calculated. We also calculated multivariate-adjusted (that is, age, sex,
physical activity, smoking, menopausal status, total EI) means for
features of the MS. Analysis of covariance with Bonferroni
correction was used to compare these means. The analysis of
concordance using the Kendall rank correlation was calculated to
measure concordance between WC and BMI. Linear regression
models were used to impute waist at 1 year. Models included age,
sex, and BMI 1 year after transplant. Covariate data from those
missing waists were then entered into the models to impute the
missing waists. To determine the associations of dietary patterns
with MS, we used multivariable logistic regression. First, we
obtained age- and sex-adjusted ORs, and then we adjusted for
cigarette smoking (yes or no), physical activity (mild, moderate,
heavy), dialysis mode (none, hemodialysis, or peritoneal dialysis)
and its duration before transplantation, the cumulative dose of
steroids at 1 year after transplant, menopausal status (yes or no),
and family history of DM and stroke (yes–no). We also adjusted for
EI (kcal/d) in the third model, and finally we added baseline BMI
(kg/m2) to the logistic regression model to examine whether the
relation was mediated by obesity in the time of transplant. In all
multivariate models, the first tertile of dietary patterns score was
considered as a reference. To determine the associations of dietary
patterns with features of MS, we used multivariable logistic
regression. All analyses were adjusted for age, sex, cigarette smoking,
physical activity, dialysis mode, and its duration before transplanta-
tion, the cumulative dose of steroids at 1 year after transplant,
menopausal status, family history of DM and stroke, EI and baseline
BMI. Finally means for BMI changes from baseline across tertiles of
dietary pattern scores were analyzed using ANOVA. We used SPSS
software (version 15; SPSS, Chicago IL, USA) for all statistical
analyses.
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